Retail Clinics

  • Walgreens continues vitamin D giveaway program with Aetna, United Way

    COLUMBIA , S.C. (May 27) One of the nation's largest drug store chains has teamed up with a healthcare benefits company and a community solutions provider to raise awareness of the need for adequate vitamin D intake.

    Walgreens, Aetna and United Way of the Midlands are continuing their efforts through a vitamin D giveaway program extension, which initially was kicked off earlier this year. The vitamin D awareness efforts will donate more than 25,000 samples, the companies said.

  • Surescripts launches open platform for docs

    NEW ORLEANS Opening another front in its long campaign to extend electronic prescribing and health information technology throughout the United States, e-prescribing platform provider Surescripts said Monday that it will expand its nationwide e-prescribing network to accelerate the digital transformation of the nation’s healthcare system by enabling the electronic exchange of all types of clinical information.

  • Novartis: Menveo protects infants against meningococcal disease

    BASEL, Switzerland An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in infants, according to results of a late-stage clinical trial released Monday.

     

    The Swiss drug maker said results of a phase-3 trial showed that Menveo (meningococcal group A, C, W135 and Y) induced immune responses in a high percentage of babies against four strains of the bacteria. Meningococcal disease occurs suddenly and can cause serious illness and often death during the first year of life.

     

     

  • Cirrus' ClearEars can relieve glue ear

    COLD SPRING HARBOR, N.Y. Cirrus Healthcare Products recently announced the launch of ClearEars, earplugs that contain a polymer to draw water from the ears after water activities. Consumers with glue ear, a condition in which thick, sticky fluid collects behind the eardrum, discovered that ClearEars helps to alleviate this condition, the company said.

     

  • MinuteClinic offers free A1c tests in line with American Diabetes Month

    WOONSOCKET, R.I. In recognition of American Diabetes Month in November, MinuteClinic is offering complimentary A1c tests beginning Oct. 25 through Nov. 25, CVS Caremark has announced. The free tests, sponsored by Bayer Diabetes Care, are available while supplies last.

  • Hospira's generic Zosyn enters market

    LAKE FOREST, Ill. Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday.

     

    The company, which specializes in generic injectables, announced the launch of piperacillin and tazobactam for injection. The drug is a generic version of Pfizer’s Zosyn.

     

     

    Various versions of the drug had sales of $797 million during the 12-month period ended in August, according to IMS Health. Sandoz, the generics division of Novartis, also launched its own version of the drug Thursday.

  • AP poll finds Americans evenly divided on impact, benefits of health-reform law

    WASHINGTON Seven months after President Obama signed the massive health-reform bill into law, Americans remain deeply divided over the controversial overhaul and its potential benefits, a new poll from the Associated Press and the GfK Group revealed.

     

  • 'Picture This' forums bring diabetes management awareness to public

    PRINCETON, N.J. A few days after it released a report on how awareness and education play an integral role in the prevention, detection and treatment of diabetes, Novo Nordisk is bringing it to the public.

  • Sandoz introduces generic Zosyn

    PRINCETON, N.J. Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis said Thursday.

     

    Sandoz announced the launch of piperacillin and tazobactam for injection. The drug is used to treat moderate to severe infections of bacteria resistant to piperacillin alone but vulnerable to the combination of the two drugs.

     

     

  • Diabetes prevalence among Americans may increase to 33%, CDC study finds

    ATLANTA The rate of diabetes among Americans is on an upswing and likely will reach epic proportions by 2050, costing the government millions.

     

X
This ad will auto-close in 10 seconds